CompletedNot Applicable

ELTGOL and Bronchiectasis. Respiratory Therapy

Spain44 participantsStarted 2011-09

Plain-language summary

The ELTGOL technique improves mucociliary clearance in adult patients with bronchiectasis. Primary objective: -To evaluate the efficacy of ELTGOL in stable state patients with bronchiectasis compared to placebo. Secondary objectives: * To evaluate the level of knowledge of airway clearance techniques and adherence to them in patients with bronchiectasis. * To assess the side effects during the procedure: oxygen desaturation, increased dyspnea and hemoptysis.

Who can participate

Age range

18 Years – 95 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All subjects ≥ 18 years old. * Diagnosis of bronchiectasis using a high-resolution computed tomography (HRCT) chest scan performed in the last 2 years. * Clinically stable disease (defined as no requirement for antibiotics for exacerbation in the 4 weeks preceding study entry. * Chronic sputum expectoration \>10ml/24h. Exclusion Criteria: * Bronchiectasis secondary to cystic fibrosis. * Inability to perform physiotherapy techniques. * Inability to attend the following controls. * Treatment with mucolytics, DNase or hypertonic saline during the study. * Smokers and ex-smokers ≥ 10 pack/year.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

To evaluate the efficacy of ELTGOL in stable state patients with bronchiectasis compared to placebo

Timeframe: 1 year

Trial details

NCT IDNCT01578681

SponsorInstitut d'Investigació Biomèdica de Girona Dr. Josep Trueta

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2011-09

View on ClinicalTrials.gov More Respiratory; Complications, Therapy trials